Supplemental material
Emerging Microbes & Infections
Volume 7, 2018 - Issue 1
Related Research Data
Ebolavirus VP35 is a multifunctional virulence factor
Source:
Informa UK Limited
Functions of Antibodies
Source:
American Society for Microbiology
Basic Residues within the Ebolavirus VP35 Protein Are Required for Its Viral Polymerase Cofactor Function
Source:
American Society for Microbiology
Intracellular Crosslinking of Filoviral Nucleoproteins with Xintrabodies Restricts Viral Packaging.
Source:
Frontiers Media SA
Ebola Virus Protein VP35 Impairs the Function of Interferon Regulatory Factor-Activating Kinases IKKε and TBK-1
Source:
American Society for Microbiology
Clinical Management of Filovirus-Infected Patients
Source:
MDPI AG
Treatment of Ebola Virus Disease
Source:
Wiley
Unveiling a Drift Resistant Cryptotope within Marburgvirus Nucleoprotein Recognized by Llama Single-Domain Antibodies
Source:
Frontiers Media SA
EBOV VP35 IID-dsRNA
Source:
Wiley
Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus.
Source:
Frontiers Media SA
UniProt: the universal protein knowledgebase
Source:
Oxford University Press (OUP)
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
Source:
American Association for the Advancement of Science (AAAS)
Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study
Source:
Elsevier BV
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
Source:
Springer Science and Business Media LLC
Treatment of Ebola Virus Disease
Source:
Wiley
Targeted Intracellular Delivery of Antibodies: The State of the Art
Source:
Frontiers Media SA
Therapeutic Intervention of Ebola Virus Infection in Rhesus Macaques with the MB-003 Monoclonal Antibody Cocktail
Source:
American Association for the Advancement of Science (AAAS)
Neutralizing Antibody Fails to Impact the Course of Ebola Virus Infection in Monkeys
Source:
Public Library of Science (PLoS)
UniProt: the universal protein knowledgebase
Source:
Oxford University Press (OUP)
Relevance of Ebola virus VP35 homo-dimerization on the type I interferon cascade inhibition.
Source:
SAGE Publications
Activation of IFN-β expression by a viral mRNA through RNase L and MDA5.
Source:
Proceedings of the National Academy of Sciences
Homo-oligomerization facilitates the interferon-antagonist activity of the ebolavirus VP35 protein
Source:
Elsevier Inc.
Small molecule inhibitors of ebola virus infection.
Source:
Elsevier BV
The Ebola virus VP35 protein functions as a type I IFN antagonist.
Source:
Proceedings of the National Academy of Sciences
Gene-Specific Countermeasures against Ebola Virus Based on Antisense Phosphorodiamidate Morpholino Oligomers
Source:
Public Library of Science (PLoS)
UniProt: the universal protein knowledgebase
Source:
Oxford University Press (OUP)
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
Source:
Elsevier BV
Human transbodies that interfere with the functions of Ebola virus VP35 protein in genome replication and transcription and innate immune antagonism
Source:
Taylor & Francis
VBASE2, an integrative V gene database
Source:
Oxford University Press (OUP)
Pathophysiology of Ebola Virus Infection: Current Challenges and Future Hopes
Source:
American Chemical Society (ACS)
Ebola Hemorrhagic Fever: Evaluation of Passive Immunotherapy in Nonhuman Primates
Source:
Oxford University Press (OUP)
Protective Efficacy of Neutralizing Monoclonal Antibodies in a Nonhuman Primate Model of Ebola Hemorrhagic Fever
Source:
The Public Library of Science
Successful Treatment of Ebola Virus–Infected Cynomolgus Macaques with Monoclonal Antibodies
Source:
American Association for the Advancement of Science (AAAS)
Shed GP of Ebola virus triggers immune activation and increased vascular permeability.
Source:
HAL CCSD
Linking provided by
